Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-51.3
Price to sales ratio
2 326.88

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
386
ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
286.24 USD-4.19%-9.06%-0.94%-9.11%38.22 B USD
496
MRNA
Moderna, Inc. - Common Stock
66.76 USD-2.21%-18.01%+33.57%+100.42%26.49 B USD
517
RPRX
Royalty Pharma plc - Class A Ordinary Shares
56.38 USD-0.09%-1.85%+1.59%+51.32%25.07 B USD
536
INSM
Insmed Incorporated - Common Stock
109.07 USD-5.66%-2.98%+13.76%-32.69%23.64 B USD

Frequently asked questions about Roivant Sciences Ltd. - Common Shares

What is the Roivant Sciences Ltd. - Common Shares stock price today?

The current price of Roivant Sciences Ltd. - Common Shares (ROIV) is 34.48. Over the past 24 hours, the stock has changed by -4.14%. Follow the ROIV chart for real-time price dynamics.

What is the stock ticker of Roivant Sciences Ltd. - Common Shares?

Roivant Sciences Ltd. - Common Shares trades under the ticker ROIV. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Roivant Sciences Ltd. - Common Shares stock going up?

ROIV has changed by -2.43% over the last week, +14.93% over the last month, and +88.31% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Roivant Sciences Ltd. - Common Shares have?

As of the latest available data, Roivant Sciences Ltd. - Common Shares has 721 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Roivant Sciences Ltd. - Common Shares stock?

You can buy Roivant Sciences Ltd. - Common Shares (ROIV) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Roivant Sciences Ltd. - Common Shares stock?

Investing in Roivant Sciences Ltd. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ROIV chart and related analysis on metatrader.com as part of your research.

Roivant Sciences Ltd. - Common Shares

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

News